Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
05/02/1997 | EP0769946A1 Methods of maintaining teeth and oral bone |
05/01/1997 | WO1997015592A1 Novel human cysteine protease |
05/01/1997 | WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
05/01/1997 | WO1997015561A1 Chiral methyl phenyl oxazolidinones |
05/01/1997 | WO1997015289A1 Solubilisation methods |
05/01/1997 | CA2235575A1 Novel human cysteine protease |
05/01/1997 | CA2235487A1 Solubilisation methods |
05/01/1997 | CA2229617A1 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation |
05/01/1997 | CA2188634A1 1ó,26 dihydroxy-d-homo-vitamin d3 |
04/30/1997 | CN1148500A Medicine for quickly curing osteoproliferation |
04/30/1997 | CN1034733C Spiro piperidines and homologs which promote release of growth hormone |
04/29/1997 | US5624940 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
04/24/1997 | WO1997014429A1 Stable pharmaceutical forms of administration containing parathormone |
04/24/1997 | WO1997014376A1 Bone grafting matrix |
04/24/1997 | WO1997009348A3 Orphan receptor |
04/24/1997 | DE19540475A1 Chirale Methylphenyloxazolidinone Chiral methylphenyloxazolidinones |
04/24/1997 | DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives |
04/24/1997 | DE19538687A1 Stabile pharmazeutische Darreichungsformen enthaltend Parathormon The stable pharmaceutical dosage forms containing parathyroid hormone |
04/24/1997 | CA2234724A1 Stable pharmaceutical forms of administration containing parathyroid hormone |
04/23/1997 | CN1148341A Oral liquid alendronate formulations |
04/23/1997 | CN1147961A Stable liquid composition containing urate oxidase and lyophilized composition for its prepn. |
04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
04/22/1997 | US5622982 Enzyme inhibitors; antiinflammatory agents |
04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
04/22/1997 | US5622721 Dosage forms of risedronate |
04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
04/17/1997 | WO1997013764A1 Lipophilic benzothiophenes |
04/17/1997 | CA2234267A1 Lipophilic benzothiophenes |
04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
04/16/1997 | EP0767792A1 Vitronectin receptor antagonists |
04/16/1997 | EP0656780B1 Drugs containing diphosphonic acids and salts thereof |
04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
04/15/1997 | US5621009 Chondroprotective agents |
04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
04/15/1997 | CA2110410C Therapeutic compositions for osteoinduction |
04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
04/09/1997 | CN1147254A Prodrugs of morpholine tachykinin receptor antagonists |
04/09/1997 | CN1034497C Process for preparation of aromatic amino-alcohol derivs. having antidiabetic and anti-obesity properties |
04/08/1997 | US5618835 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
04/08/1997 | US5618558 Fatty acid treatment |
04/08/1997 | US5618549 Bone diseases such as osteoporosis |
04/03/1997 | WO1997012036A2 Bone stimulating factor |
04/03/1997 | WO1997011718A1 Inhibitors of integrin receptors and their therapeutical uses |
04/03/1997 | WO1997011692A2 Protein tyrosine kinase inhibitors for treating osteoarthritis |
04/03/1997 | CA2233138A1 Inhibitors of integrin receptors and their therapeutical uses |
04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
04/02/1997 | CN1146355A Dianyansan powder medicine for acute waist sprain and preparation method thereof |
04/02/1997 | CN1146352A Gujinkang traditional Chinese medicine and preparation method |
04/02/1997 | CN1146343A External compress paste for discopathy |
04/01/1997 | US5616560 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
03/27/1997 | WO1997011053A1 Calcitriol derivatives and their uses |
03/26/1997 | EP0764645A1 Novel 3,4-diaryl furans and analogs thereof having use as anti-inflammatory agents |
03/26/1997 | EP0764644A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a gastrointestinal condition |
03/26/1997 | EP0764208A1 Bmp-9 compositions |
03/26/1997 | EP0764204A1 HUMAN OXALYL-CoA DECARBOXYLASE |
03/26/1997 | EP0559751B1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
03/26/1997 | CN1146152A Use of bisphophonates for inhibiting bone resorption following |
03/25/1997 | US5614649 Treatment of muscular disorders, substituted guanidines |
03/25/1997 | US5614625 Collagenase inhibitors |
03/25/1997 | US5614535 Adhesion receptor antagonists |
03/25/1997 | US5614531 Adhesion receptor antagonists |
03/25/1997 | US5614513 Release agent binder for vitamin d compounds and derivatives |
03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
03/25/1997 | US5614213 Use of estriol for treatment of climacteric osteoporosis |
03/20/1997 | WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
03/20/1997 | WO1997009992A1 Lipid extract having anti-inflammatory activity |
03/19/1997 | EP0763055A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
03/19/1997 | EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
03/19/1997 | EP0762883A1 Pyridylbisphosphonates for use as a therapeutical agent |
03/19/1997 | EP0762882A1 Vitronectin receptor antagonists |
03/19/1997 | CN1145251A Pill for removing rheumatism |
03/19/1997 | CN1145246A Chinese medicine "Juhongdan" for bone wound |
03/18/1997 | US5612356 Retinoid antagonists |
03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
03/13/1997 | WO1997009348A2 Orphan receptor |
03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
03/13/1997 | WO1997009044A1 Pentacyclic compounds, intermediates, processes, compositions, and methods |
03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
03/13/1997 | CA2230974A1 Pentacyclic compounds, intermediates, processes, compositions, and methods |
03/12/1997 | EP0761669A2 Pentacyclic compounds, intermediates, processes, compositions, and methods |
03/12/1997 | EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments |
03/12/1997 | EP0760658A1 Compounds for inhibiting osteoclast-mediated bone resorption |
03/12/1997 | EP0760598A1 Meniscal augmentation device |
03/12/1997 | CN1144667A Powder medicine for setting broken bone and its usage |
03/11/1997 | US5610178 Macrolides and the use thereof |
03/11/1997 | US5610168 Methods of use for inhibiting bone loss and lowering serum cholesterol |
03/06/1997 | WO1997008174A1 Interleukin converting enzyme and apoptosis |
03/06/1997 | WO1997007828A1 Therapy for cellular accumulation in chronic inflammatory diseases |
03/06/1997 | WO1997007815A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
03/06/1997 | WO1997007805A1 Interleukin converting enzyme and apoptosis |
03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |